57 results
S-1/A
EX-10.26
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
9 Nov 20
IPO registration (amended)
2:05pm
, LLC, a Delaware limited liability company, having an address of 10770 Wateridge Circle, Suite 200, San Diego, CA 92121 (“Supplier”). Customer … and Supplier may be referred to herein individually as a “Party” or collectively as the “Parties”.
WHEREAS, Customer desires to obtain a supply of Product
8-K
EX-10.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
3 Sep 21
Entry into a Material Definitive Agreement
4:05pm
and replacing it with the following:
3.5 Billing. Supplier shall submit invoices to Customer as outlined in SCHEDULE 3.2 to the address designated … in the applicable Order. Supplier shall include the following information on all invoices: the applicable Order number and billing address; and shall also
8-K
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
27 Jul 23
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
4:11pm
with its acquisition of Integrated DNA Technologies (“IDT”), a supplier of custom nucleic acids, where he served as President of the IDT business under
8-K
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
3 Oct 22
Maravai LifeSciences Announces CEO Leadership Transition
4:07pm
Technologies (“IDT”), a supplier of custom nucleic acids, where he served as President of the IDT business under Danaher’s ownership from April 2018 to July
8-K
EX-2.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
, Significant Distributor or Significant Supplier; or
(xxii)agreed to or entered into any commitment to effectuate any of the foregoing.
(m)Material … of $50,000 each;
(B)Contracts for capital expenditures in excess of $50,000 each;
(C)Contracts with any Significant Direct Customer, Significant Supplier
8-K
EX-10.8
v2yfplueskqoz8yv
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.10
3d7vg0r2cgk55z
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.9
wvsz4j kjuz
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
S-1
EX-10.23
rvopll
29 Oct 20
IPO registration
5:04pm
DRS/A
EX-10.23
3m33q
14 Oct 20
Draft registration statement (amended)
12:00am
S-1
EX-10.21
c90twwdj
29 Oct 20
IPO registration
5:04pm
DRS/A
EX-10.21
psiqktatl9
14 Oct 20
Draft registration statement (amended)
12:00am
S-1
EX-10.5
vpl6 fb9e9nh7
29 Oct 20
IPO registration
5:04pm